Summary
Graftys SA (Graftys) is a medical device company that develops, manufacture and commercializes synthetic bioactive orthopedic biomaterials. The company provides range of synthetic and bioresorbable bone graft substitutes and other cement products. It offers Graftys QuickSet, calcium phosphate cement, and Graftys HBS, an injectable calcium phosphate bone graft substitute. Graftys products find application in bone reconstructive and trauma surgery; fracture repair, complex fractures, tibial osteotomy and joint arthroplasty, among others. The company works in partnership with research institutions in France for the development of its product pipeline. It has a presence in France and the US. Graftys is headquartered in Aix-en-Provence, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Graftys SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
- Graftys SA Company Overview
- Graftys SA Company Snapshot
- Graftys SA Pipeline Products and Ongoing Clinical Trials Overview
- Graftys SA – Pipeline Analysis Overview
- Graftys SA - Key Facts
- Graftys SA - Major Products and Services
- Graftys SA Pipeline Products by Development Stage
- Graftys SA Pipeline Products Overview
- 3D Matrices
- 3D Matrices Product Overview
- GRFT-M03
- GRFT-M03 Product Overview
- GRFT-M04
- GRFT-M04 Product Overview
- GRFT-M05
- GRFT-M05 Product Overview
- GRFT-R02
- GRFT-R02 Product Overview
- Injectable Resorbable Material
- Injectable Resorbable Material Product Overview
- Intelligent Bone Substitute - Infection
- Intelligent Bone Substitute - Infection Product Overview
- Intelligent Bone Substitute - Post-Operative Intraosseous Pain
- Intelligent Bone Substitute - Post-Operative Intraosseous Pain Product Overview
- Graftys SA - Key Competitors
- Graftys SA - Key Employees
- Graftys SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Graftys SA, Recent Developments
- Jul 06, 2016: Graftys granted key U.S. patent for GRFT-R02, a highly osteogenic biomaterial
- Apr 26, 2016: Graftys announces regulatory clearance of Graftys Quickset in Australia and in Canada
- Mar 31, 2016: GRAFTYS strengthens its management and operations
- Nov 16, 2015: Graftys Announces Creation of an International Implant Registry to Follow up Graftys QuickSet
- Nov 16, 2015: Graftys Announces Creation of an International Implant Registry to Follow up Graftys HBS
- Sep 14, 2015: GRAFTYS Announces the Extension of its CE Mark for Its Calcium Phosphate Cements to Now Include GRAFTYS HBS and GRAFTYS Quickset for the Indication of Subchondral BML around the Knee Joint
- Jan 06, 2010: Graftys To Exhibit At AAOS 2010
- Jan 02, 2010: Kyeron Launches AXOZ QS
- Aug 28, 2008: Graftys Filed Graftys HBS To FDA
- Jul 25, 2008: Graftys Announces Launch Of Graftys HBS
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Graftys SA Pipeline Products and Ongoing Clinical Trials Overview
- Graftys SA Pipeline Products by Equipment Type
- Graftys SA Pipeline Products by Indication
- Graftys SA, Key Facts
- Graftys SA, Major Products and Services
- Graftys SA Number of Pipeline Products by Development Stage
- Graftys SA Pipeline Products Summary by Development Stage
- 3D Matrices - Product Status
- 3D Matrices - Product Description
- GRFT-M03 - Product Status
- GRFT-M03 - Product Description
- GRFT-M04 - Product Status
- GRFT-M04 - Product Description
- GRFT-M05 - Product Status
- GRFT-M05 - Product Description
- GRFT-R02 - Product Status
- GRFT-R02 - Product Description
- Injectable Resorbable Material - Product Status
- Injectable Resorbable Material - Product Description
- Intelligent Bone Substitute - Infection - Product Status
- Intelligent Bone Substitute - Infection - Product Description
- Intelligent Bone Substitute - Post-Operative Intraosseous Pain - Product Status
- Intelligent Bone Substitute - Post-Operative Intraosseous Pain - Product Description
- Graftys SA, Key Employees
- Graftys SA, Subsidiaries
- Glossary
- List of Figures
- Graftys SA Pipeline Products by Equipment Type
- Graftys SA Pipeline Products by Development Stage